Connect with us

Cannabis

AWH all set to acquire MOCA

mm

Published

on

AWH is planning to acquire MOCA following its plan to expand accross the United States

AWH is heading towards acquiring one of Chicago’s biggest marijuana dispensaries – MOCA. The acquisition will involve accretion of two of the company’s outlets located in the neighborhoods of Logan Square and River North, following the approval from the Illinois Department of Financial and Professional regulation.

“We are pleased to enter the third-largest city in the United States though our pending purchase of Modern Cannabis,” said the founder of AWH Abner Kurtin. “MOCA has been a leading player in the Chicago market, and we are excited to pair it with our Illinois Supply & Provisions (IS&P) dispensaries which include the top-performing retail outlet in the state in Collinsville.”

About AWH

Ascend Wellness Holdings is a vertically integrated organization with operations in Michigan, Massachusetts and Ohio. It is one of the largest privately held businesses in the cannabis industry that has redefined cannabis retail experience.

Their retail stores allow a direct interaction of the customers or patients with their product range. To blend into the digital era, they provide online ordering and in-store pick-ups to their customers. This is in addition to the tablets and digital options already offered in store.

AWH has planned even more expansions in the upcoming days. By November, the company plans to open another store in Springfield and another one in Fariview Heights by next year. It is also planning to inaugurate a 90,000 square foot greenhouse in its growing facility in Barry.

About MOCA

Medical and Recreational Cannabis Dispensaries holds two locations in Chicago. It started off as medicinal cannabis provider in 2016 but soon expanded into the recreational market as well.

The location of both MOCA dispensaries is prime and has easy access via public transit and transportation. The staff of these dispensaries is their greatest asset. It includes nurses, pharmacy as well as cannabis connoisseurs. Combined with the management team of the dispensaries, these human resources have earned MOCA the status of the best dispensary in Chicago.

The Benefits that will follow the acquisition of MOCA by AWH

At a time when most of other sectors are experiencing a slow-down, the commercial success of the cannabis industry in the state of Illinois is attracting investor interest.

Since the start of 2020, Illinois has generated over $300 million in recreational sales from the cannabis industry alone. The tax revenue it generated amounted to $52 million within the first six months of operation.

These figures have turned Illinois into one of the most high potential markets for the cannabis industry.

Since the unemployment rates have reached an all time high in this COVID-19 impacted economical crises, more tax revenue for the government means funds available to be allocated towards education, healthcare etc. With this, investors can expect further regulatory relaxations in the cannabis sector.

AWH is one of the fastest growing companies all across the USA, its acquisition of MOCA is very promising for the cannabis industry. “We always wanted to be up in Chicago and Cook County. We saw MOCA as the best opportunity by far”, said Abner Kurtin.

The co-founder of MOCA, Daniel Marks feels that the acquisition will give the company more resources, protecting product shortages.  This was said in the light of the shortages the company faced at the beginning of 2020. Although some of the shortages have been resolved but more time is needed to get back on track.

“AWH is a great fit for us. They have a clear, focused strategy and a nimble, ambitious team. Of the several partnerships we considered, AWH made the most sense for us in terms of their state and national size, growth trajectory, and company culture,” said MOCA founder Danny Marks.

Despite of all of these growth prospectives, AWH should be alert in striking a balance between retail store outlets and growing e-commerce in the cannabis industry.

 

A graduate in Bachelors of Business Administration, Yumna Haq is an ardent researcher and a dedicated writer. Having lived in three different counties, her cultural exposure is vast, allowing her to reflect more knowledge in her work. She's currently working for Cannabis Health Insider as a news writer.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Cannabis Home Delivery Services Likely to commence in Massachusetts

mm

Published

on

CCC is planning to allow cannabis home delivery services in the state of Massachusetts.

The CCC has agreed upon setting up a substructure for beginning cannabis home delivery services in the state of Massachusetts. The organization has presented a draft highlighting a timeline and new industry rules for starting the delivery services. Operations may begin in about a month.

The Commission has proposed an outline that would permit two types of delivery licenses for operators. Its limited delivery license would allow authorized personnel to make deliveries from CCC licensed retailers and dispensaries. Furthermore, the wholesale delivery license would allow operators to buy cannabis in wholesale directly from the cultivators. The purchased commodities will be allowed storage at a CCC approved warehouse facility. Warehouses are required to have a docking facility or sally port for a secure loading of delivery vehicles.

In additio.3n to these requirements, the CCC’s delivery draft regulations has fixed a $1,500 application fee for the licenses. Along with this, a $5,000 annual license fee for limited delivery licensees and a $10,000 annual license fee for wholesale delivery licensees is also proposed. As per the initial drafts, the CCC has decided to relinquish the application fee and first year license fee for limited delivery licensees. In the second year, the fees will be halved.

Chairman Steven Hoffman has pushed the Commission to provide finalized delivery regulations by October 20th. In the light of this, the CCC will shortly open a public comment period on the delivery regulations.

What would these cannabis delivery licenses mean for licentiate?

These delivery permits would allow licensees to supplement retail stores and provide new channels of recreational marijuana purchase.. Obtaining delivery licenses would provide a boost to small businesses. This is because the barriers to obtaining retail licenses are much more pronounced than the delivery category.

According to Commissioner Britte McBride, who wrote the regulations, “What we’ve done in addition to creating those two license types is also to establish new fees and fee structures, to require warehousing for wholesale delivery licensees, to authorize white labeling for wholesale delivery licensees. We’re defining specific operational requirements that will be in addition to the general operational requirements, and we are amending existing relevant regulations to incorporate the license types and the activities that they can undertake,”

Is it too early to allow cannabis home delivery services?

Is the requisition of cannabis really going to be just a phone call away?

For marijuana opponents, the idea of getting such convenient doorstep delivery is surely not going to be taken in good spirits. According to ballotpedia, about 46.34% of voters in Massachusetts were against the legalization of marijuana and its regulation as alcohol in 2016. For this particular segment of the population, home delivery of the drug may be an advancement that is taking place too fast. There will be concerns related to identity thefts, rise in crime rates, and products falling into wrong hands, particularly children.

Contrary to this, for the advocates of marijuana, this advancement of licenses would allow them a much needed convenience. Look at this from the perspective of bed-ridden medical marijuana patients. Leaving beds, let alone houses, is a painful endeavor for this segment of marijuana users. If other medications are already being delivered to their doorsteps, why cant medicinal marijuana join the delivery market?

For the recreational users, home deliveries might prove catalytic in reducing the stigma attached to marijuana usage. For years, marijuana has been shelled with the “not in my backyard” attitude. Despite of being advocates, most marijuana users have had to hide their association with the drug to curtail themselves from the society. If home delivery vans arrive right at the door step, it may lead to a normalization and acceptance of marijuana at some point.

Why allow delivery now?

Delivery of medical marijuana is not a new concept, even in the state of Massachusetts. Almost six authorized medical dispensaries have provided this service to registered patients since 2018.

If more licenses are granted for more legal businesses, illegal delivery services may be controlled right in infancy. In addition, this will also provide low cost business opportunities to aspiring market entrants.

The government provides no support to the marijuana industry due to its illegal federal status. By creating such opportunities at the state level, barriers to entry may be successfully reduced.

 

 

 

Continue Reading

Cannabis

Study Shows No Significant Mental Effects In Elderly Patients Using Medicinal Cannabis For Chronic Pains

Published

on

Cannabis for chronic pain doesn't impair brain

The elderly, often subjected to various medical conditions, need therapies and treatments as much as any other age group. Yet unfortunately, some point out that the field sometimes doesn’t get as much attention as younger groups. That may explain why pediatric doctors greatly outnumber geriatric specialists. And then, there does exist the tendency for the elderly to be more likely to be dismissed, compared to younger patients. Regardless, one of the most common aliments in the elderly is that of chronic pain in different parts of their aged bodies. Luckily, medicinal cannabis may hold the solution for them, as numerous experts find its properties useful for old people.

A recent study from Israel set out to ascertain whether or not weed would harmfully affect the cognitions of a sample of aged individuals. The participants included both middle-aged individuals and the elderly ones, as both seemed likely to have chronic pains. Furthermore, because the aim was to find effects on cognition, both types had fully-developed brains. What the scientists found may further the needle for the campaign to normalize medicinal cannabis.

The study set up strict controls and parameters to keep it as accurate as possible

The problem that arises with any diverse sample is the presence of individual differences. If not adjusted for, these can lead to a skewed data set and make the results questionable. In this case, the researchers strove to ensure all participants were as similar as possible. They were all above the age of 50, and no significant history with alcohol abuse or hard drugs. Some of the participants were on medicinal weed licenses, meaning they actively used it regularly. Others used it very sporadically. However, all abstained from cannabis use at least 3 hours prior. They also had similar education levels and all medically recognized as mentally sound.

The study included exactly 63 licensed individuals with the remaining 62 unlicensed. The male to female ratio was also about half and half, so sex didn’t affect the results. This almost even split served to better reproduce a normal distribution with acceptable standard deviations. Furthermore, they used a reliable software called ‘CogState’, which comprises of computerized cognitive exams. These exams covered everything required, from memory to attention spans.

The results indicated that regular cannabis use to treat chronic pains left no significant impact on cognition in the elderly

By all standards of scientific research methodology, the study mainly came out as a success. The results showed the initial hypothesis proved correct, and cannabis caused no major mental changes. In practically all participants, cognition was on par with normal levels and the frequent cannabis users did not vary much from rare users. Hence, the paper claimed that treating chronic pains with CBD (cannabidiol) and THC (tetrahydrocannabinol) would leave no lasting mental effects.

However, one interesting and alarming finding the study showed was an elevated risk of cardiovascular disease from cannabis. In addition, regular users also showed elevated frequencies of depression. The former of these may occur due to smoking cannabis rather than eating it. However, it does corroborate what a recent American Heart Association (AHA) paper claims.

While the study did have some limitations, it still shows important findings for those on the fence about medicinal weed

No truly scientific study can claim to have zero room for improvement. While they accounted for most extraneous factors, the biggest factor was the cross-sectional aspect. This means that due to broad generalizations about samples, the study cannot definitively establish cause and effect. Also, they didn’t account for previous medicinal histories.

However, the study still puts to rest many fears about brain damage from weed. For more on medicinal cannabis, stay tuned!

 

Continue Reading

Cannabis

Why New Jersey’s Telemedicine For Prescription Cannabis Is A Big Deal

Published

on

Telemedicine now available for prescription medicine in New Jersey

Earlier this month, legislation in New Jersey seems like it may take a turn in favor of medicinal cannabis using ‘telemedicine’. In a world, and nation, devastated by the ongoing COVID-19 pandemic, even visiting a physician may prove deadly. After all, hospitals, now overrun with emergent coronavirus cases, may become cesspools of airborne pathogens. Even healthcare providers still face significant risk of infection in their line of work. And this despite them donned in full protective gear and thoroughly disinfected regularly. As a matter of fact, going out anywhere public unnecessary remains inadvisable by the WHO and health authorities.

Recently, the members of the New Jersey state assembly convened to talk about various concerning issues. One of the biggest and most immediate issues, the plight of millions of patients needing prescription drugs at home, needing resolving. This especially held true of those requiring medicinal cannabis treatments, a drug not available at every nearby pharmacy. Therefore the members ruled to permit the use of telemedicine, a game-changing new service in the United States.

Telemedicine holds the key to quality healthcare in the middle of a dangerous pandemic

Not many outside of the medical field would immediately know what the concept refers to. Broadly speaking, telemedicine refers to any healthcare practice done without the patient and physician needing to interact in person. Looking at the etymology (the origin of the word), it’s all in the name (translating to long distance medicine). Therefore, video conferencing consultations between the patient at home and the doctor is an example of telemedicine. In addition, the purchase and delivery of prescription drugs from and to home online also counts as such.

So while it may not seem like anything more than ‘Zoom/Amazon but for medicine’, this is a gross understatement. Regular meetings, related to business, casual chatting and interviews, already occurred online before COVID-19. That classes and work began conducting over video conferences wasn’t anything unforeseeable as the pandemic grew. However, in traditional medical schools, few students receive training for how to treat patients online. After all, a good diagnosis usually comes with thorough rapport, careful inspection of the body and various examinations. So now the COVID-19 pandemic has doctors scrambling to learn an entirely new modality of work. And the concept of sitting safe at home while your lifesaving drugs come to you, risk-free is incredible.

The move comes unexpectedly, as cannabis legislation in New Jersey still holds some previous prejudices

The truth of the matter is that the United States is still a nation where recreational cannabis usage is federally illegal. And medicinal cannabis, despite modern scientific studies extolling its proven health benefits as a therapeutic agent in many conditions, as well. That means that the ‘default’ law for any state is that the drug is banned, with even possession resulting in criminal offence. The only state exceptions to this practice worked hard to exempt themselves. Even in New Jersey, recreational cannabis remains off the table, but medicinally it gained allowance.

As a result, the cannabis industry, which makes everything cannabis related (from hemp to CBD oils), doesn’t do well here. There simply isn’t a big enough market for products in states where cannabis is literally banned. In the case of New Jersey, only specially licensed dispensaries can legally sell prescription marijuana. Law makers historically have shown very little care to make medicinal weed more accessible, in addition. Furthermore, even healthcare providers may show hesitance to prescribe cannabis due to the amount of legal work required by state laws.

All in all, this move signals a step in the right direction. Hopefully, patients will receive their medications soon and safely.

 

Continue Reading

Trending

error: Content is protected !!